Previous Article | Next Article ![]()
Journal of Virology, March 2000, p. 2847-2854, Vol. 74, No. 6
Laboratory of Cellular
Oncology1 and Laboratory of Experimental
Carcinogenesis,2 National Cancer Institute,
and Laboratory of Cellular and Molecular Regulation,
National Institute of Mental Health,3
National Institutes of Health, Bethesda, Maryland 20892
Received 28 July 1999/Accepted 8 December 1999
Amphotropic murine leukemia virus (A-MuLV) utilizes the Pit-2
sodium-dependent phosphate transporter as a cell surface receptor to
infect mammalian cells. Previous studies established that infection of
cells with A-MuLV resulted in the specific down-modulation of phosphate
uptake mediated by Pit-2 and in resistance to superinfection with
A-MuLV. To study the mechanisms underlying these phenomena, we
constructed plasmids capable of efficiently expressing
0022-538X/00/$04.00+0
Subcellular Redistribution of Pit-2 Pi
Transporter/Amphotropic Leukemia Virus (A-MuLV) Receptor in
A-MuLV-Infected NIH 3T3 Fibroblasts: Involvement in
Superinfection Interference
epitope- and
green fluorescent protein (GFP)-tagged human Pit-2 proteins in
mammalian cells. Overexpression of
-epitope-tagged Pit-2
transporters in NIH 3T3 cells resulted in a marked increase in
sodium-dependent Pi uptake. This increase in Pi
uptake was specifically blocked by A-MuLV infection but not by
infection with ecotropic MuLV (E-MuLV) (which utilizes a cationic amino
acid transporter, not Pit-2, as a cell surface receptor). These data,
together with the finding that the tagged Pit-2 transporters retained
their A-MuLV receptor function, indicate that the insertion of epitope
tags does not affect either retrovirus receptor or Pi
transporter function. The overexpressed epitope-tagged transporters
were detected in cell lysates, by Western blot analysis using both
-epitope- and GFP-specific antibodies as well as with Pit-2
antiserum. Both the epitope- and GFP-tagged transporters showed almost
exclusive plasma membrane localization when expressed in NIH 3T3 cells, as determined by laser scanning confocal microscopy. Importantly, when
NIH 3T3 cells expressing these proteins were productively infected with
A-MuLV, the tagged transporters and receptors were no longer detected
in the plasma membrane but rather were localized to a punctate
structure within the cytosolic compartment distinct from Golgi,
endoplasmic reticulum, endosomes, lysosomes, and mitochondria. The
intracellular Pit-2 pool colocalized with the virus in A-MuLV-infected cells. A similar redistribution of the tagged Pit-2 proteins
was not observed following infection with E-MuLV, indicating that the
redistribution of Pit-2 is not directly attributable to general effects
associated with retroviral infection but rather is a specific consequence of A-MuLV-Pit-2 interactions.
*
Corresponding author. Mailing address: Laboratory of
Cellular Oncology, National Cancer Institute, National Institutes of Health, Bldg. 37, Room 1E14, 37 Convent Dr., Bethesda, MD 20892. Phone:
(301) 496-9247. Fax: (301) 480-0471. E-mail:
andersow{at}exchange.nih.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»